A Population-based Case-control Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a research study about the relationship between lung cancer and environmental risk factors. The purpose of this study is to try to understand the effects of trace elements such as arsenic and chromium, as well as radon on the development of lung cancer. To do this, the investigators will collect information and environmental and biologic specimens from people who live in Appalachian Kentucky who a) have lung cancer or b) don't have lung cancer and will serve as control subjects. The investigators will create a specimen repository of from these people and their residences to compare differences in many risks factors for cancer. By doing this study, the investigators hope to learn why there are more lung cancers in Kentucky's fifth Congressional District than anywhere else in the nation.
| Condition |
|---|
|
Lung Cancer |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | A Population-based Case-control Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens |
- rate of moderate to high arsenic level in cases and controls [ Time Frame: up to three years ] [ Designated as safety issue: No ]Conduct a case-control study of lung cancer and matched controls in the 5th Congressional District of Kentucky to compare rates of moderate to high arsenic in lung cancer cases and controls (primary endpoint).
Biospecimen Retention: Samples With DNA
Blood, live lymphocytes, serum, plasma, radon test kit, urine, water, soil, toenails, and hair.
| Estimated Enrollment: | 1800 |
| Study Start Date: | January 2012 |
| Estimated Study Completion Date: | October 2014 |
| Estimated Primary Completion Date: | October 2014 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
lung cancer cases
subjects with lung cancer who are greater than 17 years of age and live in Appalachian Kentucky
|
|
control subjects
subjects without lung cancer, greater than 17 who reside in Appalachian Kentucky
|
Detailed Description:
Appalachian Kentucky has one of the highest incidence rates of lung cancer in the United States. The disproportionately high incidence is not explained by tobacco alone. Preliminary analysis of trace element content in toenail samples reveals higher levels of arsenic, chromium and nickel in Appalachian Kentucky residents than elsewhere in Kentucky. Trace elements are known to promote carcinogenesis by increased oxidative stress, inflammation, DNA damage, and reduced DNA repair efficiency. These findings justify further investigation of the role that trace elements play in the development of lung cancer in this region. Hypothesis: The unexpectedly high rate of lung cancer in Appalachian Kentucky is associated with exposure to environmental carcinogens that increase oxidative stress and DNA damage.
Specific Aims Aim 1: Conduct a case-control study of lung cancer and matched controls in the 5th Congressional District of Kentucky to compare rates of moderate to high arsenic in lung cancer cases and controls.
Aim 2: Create a specimen repository of biologic and environmental samples from these subjects and their residences for analysis of DNA repair markers and, in the future, markers of oxidative stress and inflammation.
Aim 3: Fund four pilot projects which will utilize collected data from Aim 1 to develop investigators focused on lung cancer research in this study population and to generate preliminary data that will lead to independent funding.
Study Design: This is a population-based, case-control study encompassing the 5th Congressional District of Kentucky.
Relevance: This translational research and repository will fundamentally improve our understanding of the causes of the disproportionately high incidence of lung cancer in Appalachian Kentucky, foster collaboration among scientists dedicated to the study of lung cancer and provide a permanent resource to be used for future research.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
This case-control study will be performed in Appalachian Kentucky, specifically the 5th Congressional District of Kentucky and will include male and female subjects from the subset of all histologically or cytologically confirmed primary carcinoma of the lung (International Classification of Diseases-9, 162.2-162.9) over the age of 17 years old that occur in the 5th District between October 17, 20011 and November 14, 2013.
The following eligibility criteria are required for study entry and participation.
Inclusion (Lung cancer cases):
- Living persons with histologically or cytologically confirmed primary carcinoma of the lung (International Classification of Diseases-9, 162.2-162.9) between October 17, 2011 and October 16, 2013
- Age greater than 17
- Must be residents of the 5th Congressional District
- No prior history of any cancer (other than stage I and II non-melanomatous skin cancer)
- Must have a working phone
- Ability to participate in an in-person interview
- English speaking will be eligible for the study (no proxy respondents will be used)
Inclusion (Control cases):
- Age greater than 17
- No prior history of any cancer (other than stage I and II non-melanomatous skin cancer)
- Must be residents of the 5th Congressional District at the time they are matched to the case.
- Must have a working phone
- Ability to participate in an in-person interview
- English speaking will be eligible for the study (no proxy respondents will be used)
Exclusion:
- History of any cancers other than those listed above
- Non-residents of the 5th congressional district of Kentucky
- Age 17 years or less
Contacts and Locations| Contact: Susanne M Arnold, MD | 859-323-8043 | |
| Contact: Lara Sutherland | 1-866-997-6372 |
| United States, Kentucky | |
| University of Kentucky | Recruiting |
| Lexington, Kentucky, United States, 40536 | |
| Contact: Lara Sutherland 866-997-6372 | |
| Principal Investigator: Susanne M Arnold, MD | |
| Principal Investigator: | Susanne M Arnold, MD | Lucille P. Markey Cancer Center at University of Kentucky |
More Information
No publications provided
| Responsible Party: | University of Kentucky |
| ClinicalTrials.gov Identifier: | NCT01648166 History of Changes |
| Other Study ID Numbers: | W81XWH-11-1-0781 |
| Study First Received: | April 16, 2012 |
| Last Updated: | February 25, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by University of Kentucky:
|
trace element lung cancer Appalachia |
Additional relevant MeSH terms:
|
Lung Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site |
Neoplasms Lung Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 21, 2013